HealthTronics Fourth Quarter and Year-End Conference Call to Take Plac

    Business Editors/Health/Medical Writers

    AUSTIN, Texas--(BUSINESS WIRE)--Feb. 24, 2005--HealthTronics, Inc. (NASDAQ:HTRN), today announced that it will issue its financial results for the fourth quarter and fiscal year ended December 31, 2004 on Tuesday, March 1, 2005 after the stock market closes, one day earlier than previously announced. Accordingly, Brad A. Hummel, President and CEO, and John Q. Barnidge, Senior Vice President and CFO, will now conduct the accompanying conference call on Wednesday, March 2, 2005 at 10:30 am ET.
    Interested parties may participate in the call by dialing 888-743-0342 (706-679-0861 for international callers) and asking for the "HealthTronics" call (conference I.D. #3228653). Please call in 10 minutes before the call is scheduled to begin. The conference call will also be webcast live via the Investors section of the Company's web site at www.healthtronics.com. To listen to the live webcast, go to the web site at least 10 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the Company's web site.

    About HealthTronics, Inc.

    HealthTronics provides healthcare services, primarily to the urology community, and manufactures medical devices as well as specialty vehicles used for the transport of high technology medical and broadcast & communications equipment. For more information, visit www.healthtronics.com.

    Statements by the Company's management during the conference call announced in this press release that are not strictly historical, including statements regarding plans, objective and future financial performance, are "forward-looking" statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Although HealthTronics believes that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that the expectations will prove to be correct. Factors that could cause actual results to differ materially from HealthTronics' expectations include, among others, the existence of demand for and acceptance of HealthTronics' services, the integration of Prime's and HealthTronics' businesses, regulatory approvals, economic conditions, the impact of competition and pricing, financing efforts and other factors described from time to time in HealthTronics' periodic filings with the Securities and Exchange Commission.

--30--SW/sa*

CONTACT: HealthTronics, Inc., Austin Brad A. Hummel or John Q. Barnidge, 512-314-4554 www.healthtronics.com or Investor Relations Counsel: The Equity Group Inc. Loren G. Mortman, 212-836-9604 LMortman@equityny.com or Lauren Barbera, 212-836-9610 LBarbera@equityny.com www.theequitygroup.com

KEYWORD: TEXAS INDUSTRY KEYWORD: BANKING MEDICAL DEVICES MEDICAL BIOTECHNOLOGY EARNINGS CONFERENCE CALLS SOURCE: HealthTronics, Inc.

Copyright Business Wire 2005